19475511000001107: Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \UK product\Virtual medicinal product\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \UK product\Virtual therapeutic moiety\Rifaximin\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \UK product\Virtual therapeutic moiety\Rifaximin\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \UK product\Trade family\Xifaxanta\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Product containing rifaximin in oral dose form (medicinal product form)\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Product containing rifaximin in oral dose form (medicinal product form)\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Rifaximin\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing rifamycin structure and acting as antibacterial agent (product)\Product containing rifaximin\Product containing rifaximin in oral dose form (medicinal product form)\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing rifaximin in oral dose form (medicinal product form)\Product containing only rifaximin in oral dose form (medicinal product form)\Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet\Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
65831601000001115	Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
65831701000001113	Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start